Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
Walgreens profit beats, Rite Aid deal seen closing in 2017
Published Oct 20, 2016 08:43AM ET
© Reuters. The Walgreens store in Times Square seen in New York
By Sruthi Ramakrishnan
(Reuters) - Drugstore operator Walgreens Boots Alliance Inc (O:WBA) reported a better-than-expected quarterly profit, helped by cost cutting, and said it now expected its acquisition of Rite Aid Corp (N:RAD) to close on Jan. 27, three months later than planned.
Walgreens said in September it would likely have to divest between 500 and 1,000 stores to get regulatory clearance for the $9.4 billion deal.
Walgreens, the No. 1 U.S. drugstore operator by store count, had previously said it expected it would need to divest not more than 500 stores and that the deal would close on Oct. 27.
The company said it expected to divest stores to win approval for the deal by the end of 2016.
Supermarket chain Kroger Co (N:KR) is questioning whether to proceed with buying divested stores from Walgreens, a source familiar with the situation said on Wednesday, casting doubts on the future of the Walgreens-Rite Aid deal.
Kroger and Walgreens representatives declined to comment.
Walgreens wants to buy Rite Aid to widen its footprint in the United States and negotiate for lower drug costs.
Walgreens' shares were up 1.7 percent at $78.50 in premarket trading after closing at their lowest in five months on Wednesday. Rite Aid's shares were up about 4.4 percent at $6.95.
"The longer the (merger) process takes the more likely it is to close as it signals a delay in sorting out the divestiture package vs. a true blockage by FTC," Evercore ISI analyst Ross Muken wrote in a client note.
Walgreens said on Thursday its net income attributable to the company rose to $1.03 billion, or 95 cents per share, in the fourth quarter ended Aug. 31, from $26 million, or 2 cents per share, a year earlier.
The company had recorded a loss of $143 million on a previously held equity interest and $479 million in other expenses in the year-ago quarter.
Walgreens said it met its goal of achieving $1 billion in synergies in June from its Boots Alliance acquisition. It is also working on cutting $1.5 billion in costs by the end of its fiscal year ending in August 2017, including by closing about 200 stores and reorganizing operations, among other measures.
Excluding items, the company earned $1.07 per share in the quarter, beating the average analyst estimate of 99 cents per share, according to Thomson Reuters I/B/E/S.
Sales rose marginally to $28.64 billion, missing the average estimate of $29.06 billion.
Related Articles
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.